Home › Neuroblastoma › Rhode Island › Providence
Neuroblastoma clinical trials in Providence, RI
3 studies for Neuroblastoma are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Rhode Island Hospital, Providence
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Hasbro Children's Hospital, Providence
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Rhode Island Hospital, Providence
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Birmingham, AL8 studies
- Minneapolis, MN8 studies
- Aurora, CO8 studies
- Hartford, CT8 studies
- Cincinnati, OH7 studies
Other studies in Providence
- Endometrial Cancer15 studies
- Ovarian Cancer15 studies
- Obesity14 studies
- Cancer (all types)13 studies
- Crohn's Disease12 studies
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer11 studies
- Ulcerative Colitis11 studies
- Acute Myeloid Leukemia10 studies
- Overweight9 studies
- Metastatic Cancer9 studies
- Alcohol Use Disorder (AUD)8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.